List of works - Indra N Guha

A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factors.

scientific article published on 24 April 2015

Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease

scientific article published on 25 March 2018

Antibiotic prophylaxis in variceal hemorrhage: Timing, effectiveness and Clostridium difficile rates ⬇️

scientific article published on November 14, 2010

Back to the future with noninvasive biomarkers of liver fibrosis

scientific article published on 01 January 2009

Biomarkers of liver fibrosis

scientific article published on 28 June 2016

Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?

scientific article published on 09 August 2011

Case report of an arterioportal fistula, presenting with accelerated decompensation and sepsis, twenty-six years after initial liver biopsy

scientific article published on 14 July 2005

Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study

scientific article published on 9 October 2015

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography

scientific article published on 3 May 2015

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study

scientific article

Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage

scientific article published in February 2013

Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice?

scientific article published on 01 January 2020

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.

scientific article published in January 2011

Evaluation of area-based collagen scoring by nonlinear microscopy in chronic hepatitis C-induced liver fibrosis

scientific article published on 11 March 2015

F2-isoprostanes and the liver.

scientific article published on October 2003

Future use of the Glasgow alcoholic hepatitis score

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

scientific article published on 7 November 2017

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease

scientific article published on 21 February 2018

Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis.

scientific article published on 23 December 2014

Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging

scientific article published on 08 June 2018

Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.

scientific article

Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging

scientific article published on 27 July 2016

Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study

scientific article

Non-invasive monitoring of liver fibrosis.

scientific article

Non-invasive tests for the detection of oesophageal varices in compensated cirrhosis: systematic review and meta-analysis.

scientific article published on 22 March 2018

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

scientific article

Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography.

scientific article

Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans

scientific article published on September 2012

Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI tract: systematic review and meta-analysis

scientific article published on 11 September 2015

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

scientific article

Prediction, prevention and management of postresection liver failure.

scientific article

Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.

scientific article

Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis

scientific article published on 06 August 2019

REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem

scientific article

Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.

scientific article published on 7 October 2006

SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.

scientific article published on 6 November 2017

SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis

scientific article published in Scientific Reports

Screening for liver fibrosis in the general population: a call for action.

scientific article published on 12 October 2016

Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications

scientific article published on 21 June 2019

Structural and functional uncoupling of liver performance in the Fontan circulation ⬇️

scientific article published on July 23, 2011

Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease

scientific article published on 28 December 2012

The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a prospective diagnostic pilot study.

scientific article published on 28 April 2016

The effect of prone positioning with surgical bolsters on liver blood flow in healthy volunteers.

scientific article published on 7 March 2016

The performance of transient elastography compared to clinical acumen and routine tests - what is the incremental diagnostic value?

scientific article published on 8 November 2012

Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia

scientific article published on 27 August 2019

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

scientific article

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease

scientific article

Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liver disease

scientific article published on 12 September 2016

Were James Bond's drinks shaken because of alcohol induced tremor?

scientific article (publication date: 12 December 2013)

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

scientific article published on 21 July 2020

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study

scientific article

List of works by Indra N Guha

A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factors.

Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease

Antibiotic prophylaxis in variceal hemorrhage: Timing, effectiveness and Clostridium difficile rates ⬇️

Back to the future with noninvasive biomarkers of liver fibrosis

Biomarkers of liver fibrosis

Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?

Case report of an arterioportal fistula, presenting with accelerated decompensation and sepsis, twenty-six years after initial liver biopsy

Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study

Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage

Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice?

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.

Evaluation of area-based collagen scoring by nonlinear microscopy in chronic hepatitis C-induced liver fibrosis

F2-isoprostanes and the liver.

Future use of the Glasgow alcoholic hepatitis score

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease

Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis.

Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging

Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.

Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging

Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study

Non-invasive monitoring of liver fibrosis.

Non-invasive tests for the detection of oesophageal varices in compensated cirrhosis: systematic review and meta-analysis.

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography.

Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans

Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI tract: systematic review and meta-analysis

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

Prediction, prevention and management of postresection liver failure.

Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.

Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis

REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem

Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.

SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.

SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis

Screening for liver fibrosis in the general population: a call for action.

Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications

Structural and functional uncoupling of liver performance in the Fontan circulation ⬇️

Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease

The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a prospective diagnostic pilot study.

The effect of prone positioning with surgical bolsters on liver blood flow in healthy volunteers.

The performance of transient elastography compared to clinical acumen and routine tests - what is the incremental diagnostic value?

Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease

Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liver disease

Were James Bond's drinks shaken because of alcohol induced tremor?

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study